Jennifer E Miller, PhD
Associate Professor of Medicine (General Medicine)Cards
About
Research
Publications
Featured Publications
The Critical Shortage of Iodinated Contrast Material — Will Value Prevail?
Tu LH, Miller JE, Forman HP. The Critical Shortage of Iodinated Contrast Material — Will Value Prevail? New England Journal Of Medicine 2022, 387: 491-493. PMID: 35704416, DOI: 10.1056/nejmp2206996.Peer-Reviewed Original ResearchEthical considerations in international clinical trial site selection.
Miller J, Millum J. Ethical considerations in international clinical trial site selection. BMJ Global Health 2022, 7 PMID: 35387769, PMCID: PMC8987699, DOI: 10.1136/bmjgh-2021-008012.Peer-Reviewed Original ResearchAccess to COVID-19 Vaccines in High-, Middle-, and Low-Income Countries Hosting Clinical Trials
Ramachandran R, Ross JS, Miller JE. Access to COVID-19 Vaccines in High-, Middle-, and Low-Income Countries Hosting Clinical Trials. JAMA Network Open 2021, 4: e2134233. PMID: 34792596, PMCID: PMC8603077, DOI: 10.1001/jamanetworkopen.2021.34233.Peer-Reviewed Original ResearchEvaluation of Drug Trials in High-, Middle-, and Low-Income Countries and Local Commercial Availability of Newly Approved Drugs
Miller JE, Mello MM, Wallach JD, Gudbranson EM, Bohlig B, Ross JS, Gross CP, Bach PB. Evaluation of Drug Trials in High-, Middle-, and Low-Income Countries and Local Commercial Availability of Newly Approved Drugs. JAMA Network Open 2021, 4: e217075. PMID: 33950209, PMCID: PMC8100865, DOI: 10.1001/jamanetworkopen.2021.7075.Peer-Reviewed Original ResearchConceptsFDA approvalHigh-income countriesDrug approvalIncome countriesNovel drugsDrug Administration (FDA) drug approvalsRegulatory agency websitesCross-sectional analysisProportion of drugPrimary outcomeFDA drug approvalsProportion of countriesDrug trialsMAIN OUTCOMEUS FoodClinical researchCountry income levelLow-income countriesMarketing approvalTrialsGoogle ScholarDrugsDrug companiesApprovalMedian
2024
Reporting of Demographics & Subgroup Analyses in Premarketing Studies of FDA Approved High-Risk Cardiovascular Devices, 2014–2022
Swanson M, Uyeki C, Yoder S, Dhruva S, Miller J, Ross J. Reporting of Demographics & Subgroup Analyses in Premarketing Studies of FDA Approved High-Risk Cardiovascular Devices, 2014–2022. Medical Devices Evidence And Research 2024, 17: 165-172. PMID: 38707869, PMCID: PMC11067925, DOI: 10.2147/mder.s457152.Peer-Reviewed Original ResearchFood and Drug AdministrationHigh-risk cardiovascular devicesSubgroup analysisPremarketing studiesUS Food and Drug AdministrationResults of subgroup analysisParticipation of older adultsStudy participantsClinical trialsSocioeconomic positionTrial populationDrug AdministrationStudy populationConduction of subgroup analysisDemographic dataOlder adultsReporting of demographicsSubgroupsPatients' socioeconomic position.PatientsTrials
2023
Clinical Trial Diversity: A Bend in the Arc Toward Justice
Tannenbaum S, Miller J. Clinical Trial Diversity: A Bend in the Arc Toward Justice. JCO Precision Oncology 2023, 7: e2300380. PMID: 37725783, DOI: 10.1200/po.23.00380.Peer-Reviewed Original ResearchTransparency of Results Reporting in Cancer Clinical Trials
Kao J, Ross J, Miller J. Transparency of Results Reporting in Cancer Clinical Trials. JAMA Network Open 2023, 6: e2328117. PMID: 37556143, PMCID: PMC10413165, DOI: 10.1001/jamanetworkopen.2023.28117.Peer-Reviewed Original ResearchClinical Trial Diversity—Will We Know It When We See It?
Varma T, Gross C, Miller J. Clinical Trial Diversity—Will We Know It When We See It? JAMA Oncology 2023, 9: 765-767. PMID: 37022678, DOI: 10.1001/jamaoncol.2023.0143.Peer-Reviewed Original ResearchWhat is Fair Representation in Research?
Miller J, Latham S. What is Fair Representation in Research? The American Journal Of Bioethics 2023, 23: 89-91. PMID: 37220359, DOI: 10.1080/15265161.2023.2201543.Peer-Reviewed Original ResearchRanking pharmaceutical companies on clinical trial diversity
Varma T, Miller J. Ranking pharmaceutical companies on clinical trial diversity. The BMJ 2023, 380: p334. PMID: 36764687, DOI: 10.1136/bmj.p334.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
News
News
- February 27, 2023
Increasing Diversity in Clinical Trials: A Q&A With Jennifer Miller, PhD
- February 21, 2023Source: Yale News
Insights & Outcomes: Clinical trial data gaps and a universe of old milk
- February 15, 2023Source: Nature
FDA to require diversity plan for clinical trials
- February 08, 2023Source: The Conversation
Lack of diversity in clinical trials is leaving women and patients of color behind and harming the future of medicine